Quarterly report [Sections 13 or 15(d)]

SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF NET LOSS PER SHARE (Details)

v3.26.1
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF NET LOSS PER SHARE (Details) - shares
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
 [1]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 42,960,414 42,427,500 42,960,414
Warrant [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 38,341,664 38,825,000 38,341,664
Share-Based Payment Arrangement, Option [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 4,618,750 3,602,500 4,618,750
Acquisition Stock Consideration Payable [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total
[1] For the six months ended June 30, 2025, the Company reported net income and its common stock equivalents were dilutive; accordingly, no securities were excluded as anti-dilutive for that period. The effect of those dilutive securities on the weighted average number of diluted shares is presented in the reconciliation below.